{"organizations": [], "uuid": "9e89eb0c6389cd6ea7a595ffd2eab6b50cf807d4", "thread": {"social": {"gplus": {"shares": 9}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 1}, "facebook": {"likes": 229, "shares": 229, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.dailymail.co.uk", "main_image": "http://i.dailymail.co.uk/i/pix/2017/02/14/15/3D350C4100000578-0-image-a-6_1487087264353.jpg", "site_section": "", "section_title": "", "url": "http://www.dailymail.co.uk/health/article-4223902/Scandal-muscular-dystrophy-drug-price-hikes-88-000.html", "country": "GB", "domain_rank": 138, "title": "Scandal as muscular dystrophy drug price hikes $88,000 | Daily Mail Online", "performance_score": 2, "site": "dailymail.co.uk", "participants_count": 0, "title_full": "Scandal as muscular dystrophy drug price hikes $88,000 | Daily Mail Online", "spam_score": 0.985, "site_type": "news", "published": "2017-02-14T22:48:00.000+02:00", "replies_count": 0, "uuid": "9e89eb0c6389cd6ea7a595ffd2eab6b50cf807d4"}, "author": "Mia De Graaf For Dailymail.Com", "url": "http://www.dailymail.co.uk/health/article-4223902/Scandal-muscular-dystrophy-drug-price-hikes-88-000.html", "ord_in_thread": 0, "title": "Scandal as muscular dystrophy drug price hikes $88,000 | Daily Mail Online", "locations": [], "entities": {"persons": [], "locations": [{"name": "us", "sentiment": "none"}, {"name": "emflaza", "sentiment": "none"}], "organizations": [{"name": "new big pharma", "sentiment": "negative"}, {"name": "fda", "sentiment": "negative"}, {"name": "dmd duchenne", "sentiment": "none"}, {"name": "marathon pharmaceuticals", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Disease gougers: New Big Pharma scandal as FDA approves drug for terminal muscular dystrophy - but manufacturer hikes the price from $1,000 to $89,000 a year Emflaza, a steroid, is one of the only drugs known to slow the effects of DMD Duchenne's muscular dystrophy is a terminal disease that mainly affects boys Previously, families could import the drug to the US for around $1,000 a year Last week it was approved by the FDA for US use - but the manufacturer Marathon Pharmaceuticals hiked the price to $89,000 a year Now Marathon has paused the launch amid outrage from families and lawmakers Published: 15:48 GMT, 14 February 2017 | Updated: 16:31 GMT, 14 February 2017 148 shares ", "external_links": [], "published": "2017-02-14T22:48:00.000+02:00", "crawled": "2017-02-15T05:32:16.763+02:00", "highlightTitle": ""}